Insider Shareholders with Direct Ownership of Candel Therapeutics, Inc. (CADL)
This section provides a comprehensive overview of the insiders with direct ownership of Candel Therapeutics, Inc. (CADL). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Candel Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Laura K. Aguilar
> 10% Shareholder |
227,431 | 68,534 | 1,033,840 $6.15 Million | 3 |
May 06, 2022
Reduced 6.22%
|
|
Paul Peter Tak
Chief Executive Officer |
429,899 | 204,159 | 225,740 $1.34 Million | 14 |
Mar 19, 2025
Reduced 0.18%
|
|
Jason Amello
Chief Financial Officer |
222,162 | 20,153 | 202,009 $1.2 Million | 5 |
Nov 28, 2023
Reduced 9.07%
|
|
Estuardo Aguilar Cordova
> 10% Shareholder |
353,534 | 969,621 | 162,929 $969,427 | 31 |
Feb 21, 2025
Reduced 6.1%
|
| 27,000 | 0 | 152,000 $904,400 | 2 |
Dec 09, 2022
Added 13.61%
|
|
|
Francesca Barone
Chief Scientific Officer |
222,905 | 127,878 | 96,527 $574,335 | 11 |
Mar 18, 2025
Reduced 24.98%
|
|
Seshu Tyagarajan
Chief Technology Officer |
191,558 | 126,046 | 85,512 $508,796 | 11 |
Mar 17, 2025
Reduced 26.78%
|
| 56,000 | 0 | 56,000 $333,200 | 2 |
Jul 29, 2021
Added 26.32%
|
|
|
William Garrett Nichols
Chief Medical Officer |
165,790 | 113,297 | 52,493 $312,333 | 10 |
Mar 18, 2025
Reduced 46.33%
|
| 0 | 43,263 | 38,038 $226,326 | 5 |
Mar 17, 2025
Reduced 11.62%
|
|
| 38,032 | 0 | 38,032 $226,290 | 2 |
Dec 09, 2022
Added 47.94%
|
|
|
John J Canepa
Chief Financial Officer |
10,125 | 0 | 10,125 $60,243 | 1 |
Jul 29, 2021
Added 50.0%
|
| 10,000 | 0 | 10,000 $59,500 | 1 |
Jul 29, 2021
Added 50.0%
|
|
|
Nathan Caffo
Chief Business Officer |
6,000 | 0 | 6,000 $35,700 | 1 |
Jul 29, 2021
Added 50.0%
|